• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于高通量筛选的3D生物打印:药物筛选、疾病建模及精准医学应用

3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications.

作者信息

Mazzocchi Andrea, Soker Shay, Skardal Aleksander

机构信息

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center, Winston-Salem, North Carolina 27101, USA.

Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina 27157, USA.

出版信息

Appl Phys Rev. 2019 Mar;6(1). doi: 10.1063/1.5056188. Epub 2019 Feb 6.

DOI:10.1063/1.5056188
PMID:33738018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7968875/
Abstract

High-throughput technologies have become essential in many fields of pharmaceutical and biological development and production. Such technologies were initially developed with compatibility with liquid handling-based cell culture techniques to produce large-scale 2D cell culture experiments for the compound analysis of candidate drug compounds. Over the past two decades, tools for creating 3D cell cultures, organoids, and other 3D models, such as cell supportive biomaterials and 3D bioprinting, have rapidly advanced. Concurrently, a significant body of evidence has accumulated which speaks to the many benefits that 3D model systems have over traditional 2D cell cultures. Specifically, 3D cellular models better mimic aspects such as diffusion kinetics, cell-cell interactions, cell-matrix interactions, inclusion of stroma, and other features native to tissue and as such have become an integral part of academic research. However, most high throughput assays were not developed to specifically support 3D systems. Here, we describe the need for improved compatibility and relevant advances toward deployment and adoption of high throughput 3D models to improve disease modeling, drug efficacy testing, and precision medicine applications.

摘要

高通量技术在药物和生物研发及生产的许多领域已变得至关重要。此类技术最初是为了与基于液体处理的细胞培养技术兼容而开发的,用于进行大规模二维细胞培养实验,以分析候选药物化合物。在过去二十年中,用于创建三维细胞培养物、类器官和其他三维模型的工具,如细胞支持性生物材料和三维生物打印技术,取得了迅速进展。与此同时,大量证据表明三维模型系统相对于传统二维细胞培养具有诸多优势。具体而言,三维细胞模型能更好地模拟扩散动力学、细胞间相互作用、细胞与基质相互作用、基质包含以及组织固有的其他特征等方面,因此已成为学术研究不可或缺的一部分。然而,大多数高通量检测方法并非专门为支持三维系统而开发。在此,我们描述了提高兼容性的必要性以及在部署和采用高通量三维模型方面的相关进展,以改善疾病建模、药物疗效测试和精准医学应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/369ce47f0e1a/nihms-1680334-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/38b3d1bc7909/nihms-1680334-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/37496f6b20c2/nihms-1680334-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/369ce47f0e1a/nihms-1680334-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/38b3d1bc7909/nihms-1680334-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/37496f6b20c2/nihms-1680334-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/306f/7968875/369ce47f0e1a/nihms-1680334-f0003.jpg

相似文献

1
3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications.用于高通量筛选的3D生物打印:药物筛选、疾病建模及精准医学应用
Appl Phys Rev. 2019 Mar;6(1). doi: 10.1063/1.5056188. Epub 2019 Feb 6.
2
Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.生物工程 3D 组织和肿瘤类器官在药物开发和精准医学中的应用:现状与未来。
BioDrugs. 2018 Feb;32(1):53-68. doi: 10.1007/s40259-017-0258-x.
3
3D bioprinting for drug discovery and development in pharmaceutics.用于制药领域药物发现与开发的3D生物打印技术。
Acta Biomater. 2017 Jul 15;57:26-46. doi: 10.1016/j.actbio.2017.05.025. Epub 2017 May 10.
4
Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow.通过新型生物打印工作流程实现 3D 细胞培养中的高通量药物发现。
SLAS Technol. 2022 Feb;27(1):32-38. doi: 10.1016/j.slast.2021.10.002. Epub 2021 Oct 25.
5
Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform.利用易于使用的生物打印平台培养大规模 3D 乳腺上皮结构的一致性和可重复性。
Breast Cancer Res. 2018 Oct 10;20(1):122. doi: 10.1186/s13058-018-1045-4.
6
3D in vitro corneal models: A review of current technologies.3D 体外角膜模型:当前技术综述。
Exp Eye Res. 2020 Nov;200:108213. doi: 10.1016/j.exer.2020.108213. Epub 2020 Sep 3.
7
3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.用于疾病建模和药物测试的眼部组织的 3D 工程。
Adv Exp Med Biol. 2019;1186:171-193. doi: 10.1007/978-3-030-28471-8_7.
8
Bioprinting technologies for disease modeling.用于疾病建模的生物打印技术。
Biotechnol Lett. 2017 Sep;39(9):1279-1290. doi: 10.1007/s10529-017-2360-z. Epub 2017 May 26.
9
3D Cell Cultures: Evolution of an Ancient Tool for New Applications.3D细胞培养:古老工具在新应用中的演变
Front Physiol. 2022 Jul 22;13:836480. doi: 10.3389/fphys.2022.836480. eCollection 2022.
10
Bioengineered Tumor Organoids.生物工程肿瘤类器官
Curr Opin Biomed Eng. 2020 Mar;13:168-173. doi: 10.1016/j.cobme.2020.03.005. Epub 2020 Apr 1.

引用本文的文献

1
Innovative strategies for bone organoid: Synergistic application and exploration of advanced technologies.骨类器官的创新策略:先进技术的协同应用与探索
J Orthop Translat. 2025 Aug 14;54:180-198. doi: 10.1016/j.jot.2025.07.010. eCollection 2025 Sep.
2
Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?用于药物筛选的生物打印:是减少动物实验的途径还是重新定义临床前研究?
Bioact Mater. 2025 Jul 15;51:993-1017. doi: 10.1016/j.bioactmat.2025.07.006. eCollection 2025 Sep.
3
ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response.

本文引用的文献

1
Engineering innervated secretory epithelial organoids by magnetic three-dimensional bioprinting for stimulating epithelial growth in salivary glands.通过磁三维生物打印工程化有神经支配的分泌上皮类器官,以刺激唾液腺中的上皮生长。
Biomaterials. 2018 Oct;180:52-66. doi: 10.1016/j.biomaterials.2018.06.011. Epub 2018 Jun 12.
2
3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.三维生物打印功能组织模型用于个性化药物筛选和体外疾病建模。
Adv Drug Deliv Rev. 2018 Jul;132:235-251. doi: 10.1016/j.addr.2018.06.011. Epub 2018 Jun 21.
3
Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
用于研究硬度依赖性肿瘤行为和药物反应的非小细胞肺癌的细胞外基质表征及3D生物打印模型
Mater Today Bio. 2025 Apr 30;32:101823. doi: 10.1016/j.mtbio.2025.101823. eCollection 2025 Jun.
4
Pancreatic 3D Organoids and Microfluidic Systems-Applicability and Utilization in Surgery: A Literature Review.胰腺3D类器官与微流控系统——在手术中的适用性与应用:文献综述
Medicina (Kaunas). 2025 Mar 28;61(4):623. doi: 10.3390/medicina61040623.
5
Development of a 3D bioengineered human lung submucosal gland ductal airway model to study mucociliary clearance .用于研究黏液纤毛清除功能的三维生物工程化人肺黏膜下腺导管气道模型的开发。
Cell Biomater. 2025 Mar 25;1(2). doi: 10.1016/j.celbio.2025.100013. Epub 2025 Mar 3.
6
Advanced passive 3D bioelectronics: powerful tool for the cardiac electrophysiology investigation.先进的无源3D生物电子学:心脏电生理学研究的强大工具。
Microsyst Nanoeng. 2025 Mar 17;11(1):50. doi: 10.1038/s41378-025-00891-w.
7
3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns.用于构建药物测试模型的3D生物打印——发展策略与监管问题
Front Bioeng Biotechnol. 2025 Feb 14;13:1457872. doi: 10.3389/fbioe.2025.1457872. eCollection 2025.
8
Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review.评估涉及生物打印的临床试验和观察性研究的现状:一项范围综述
3D Print Med. 2025 Feb 17;11(1):5. doi: 10.1186/s41205-025-00253-2.
9
Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models.肾纤维化的体外和体内模型:迈向生理相关人源化模型的路径。
Adv Healthc Mater. 2025 Apr;14(9):e2403230. doi: 10.1002/adhm.202403230. Epub 2025 Feb 5.
10
Extrusion bioprinting: meeting the promise of human tissue biofabrication?挤出式生物打印:能否兑现人体组织生物制造的承诺?
Prog Biomed Eng (Bristol). 2025 Mar 11;7(2):023001. doi: 10.1088/2516-1091/adb254.
用于高通量表型药物筛选的原发性胰腺类器官肿瘤模型的高级开发。
SLAS Discov. 2018 Jul;23(6):574-584. doi: 10.1177/2472555218766842. Epub 2018 Apr 19.
4
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.体外患者来源的 3D 间皮瘤肿瘤类器官促进以患者为中心的治疗筛选。
Sci Rep. 2018 Feb 13;8(1):2886. doi: 10.1038/s41598-018-21200-8.
5
Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.生物工程 3D 组织和肿瘤类器官在药物开发和精准医学中的应用:现状与未来。
BioDrugs. 2018 Feb;32(1):53-68. doi: 10.1007/s40259-017-0258-x.
6
Synthetic hydrogels for human intestinal organoid generation and colonic wound repair.用于生成人类肠道类器官和修复结肠伤口的合成水凝胶。
Nat Cell Biol. 2017 Nov;19(11):1326-1335. doi: 10.1038/ncb3632. Epub 2017 Oct 23.
7
Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture.优化搅拌悬浮培养中的人诱导多能干细胞扩增。
Stem Cells Dev. 2017 Dec 15;26(24):1804-1817. doi: 10.1089/scd.2017.0090. Epub 2017 Nov 21.
8
RGD-functionalized polyethylene glycol hydrogels support proliferation and in vitro chondrogenesis of human periosteum-derived cells.RGD 功能化聚乙二醇水凝胶支持人骨膜来源细胞的增殖和体外软骨分化。
J Biomed Mater Res A. 2018 Jan;106(1):33-42. doi: 10.1002/jbm.a.36208. Epub 2017 Sep 23.
9
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.多组织相互作用的集成三组织器官芯片平台。
Sci Rep. 2017 Aug 18;7(1):8837. doi: 10.1038/s41598-017-08879-x.
10
Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy.间充质干细胞支持宿主肝脏结直肠肿瘤类器官的生长和组织构建,并可能赋予其化疗抗性。
Biofabrication. 2017 Jun 7;9(2):021002. doi: 10.1088/1758-5090/aa7484.